Oligoclonal bands and antibody responses in Multiple Sclerosis

Journal of Neurology

Volumn 249, Issue 4, 2002, Pages 375-389

  Correale, Jorge ^a,b   De los Milagros Bassani Molinas, María ^c  

^a Instituto de Investigaciones Neurologicas Raul Carrera   (Argentina)

^b UNIVERSIDAD AUSTRAL   (Argentina)

^c Instituto de Investigaciones Neurológicas   (Argentina)

Author keywords

Antibodies; Autoimmunity; B cells; Multiple Sclerosis; Oligoclonal bands

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; AUTOANTIBODY; AUTOANTIGEN; CORTICOSTEROID; CORTICOTROPIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN M; MYELIN;

ANTIBODY RESPONSE; ANTIGEN RECOGNITION; CELLULAR IMMUNITY; CEREBROSPINAL FLUID ANALYSIS; DEMYELINATION; DISEASE COURSE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOGLOBULIN PRODUCTION; LABORATORY TEST; MULTIPLE SCLEROSIS; MYELIN SHEATH; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; REMYELINIZATION; REVIEW; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODY FORMATION; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS; MULTIPLE SCLEROSIS; OLIGOCLONAL BANDS;

EID: 0036223573     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150200026     Document Type: Review

References (198)

1. Cerebrospinal fluid in the diagnosis of multiple sclerosis: A consensus report
2. Isolation and characterization of an oligodendrocyte precursor-derived B cell epitope in multiple sclerosis
3. Targeting of IgM kappa antibodies to oligodendrocytes promotes CNS remyelination
4. A unique population of circulating autoantibodies promotes central nervous system remyelination
5. Multiple sclerosis: Cells secreting antibodies against myelin-associated glycoprotein are present in cerebrospinal fluid
6. Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis
7. B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions
8. Formulas for the quantitation of intrathecal IgG production. Their validity in the presence of blood-brain barrier damage and their utility in multiple sclerosis
9. A humoral response to oligodendrocyte-specific protein in MS. A potential molecular mimic
10. Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies
11. IgA producing primary intracerebral lymphoma
12. Apport de la focalisation isoélectrique del immunoglobulines G du liquide céphalorachidien dans le bilan biologique precoce de la sclerose en plaques
13. The predictive value of CSF oligoclonal banding for MS 5 years after optic neuritis
14. Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients
15. Immunocytochemical localization of the terminal complement complex in multiple sclerosis
16. Silver stain of unconcentrated cerebrospinal fluid: Preliminary results in multiple sclerosis and other neurological diseases
17. Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries
18. B cells and antibodies in CNS demyelinating disease
19. Immunoblot detection of oligoclonal anti-myelin basic protein IgG antibodies in cerebrospinal fluid in multiple sclerosis
20. A solid phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody secreting cells
21. Free light chains in multiple sclerosis and infections of the CNS
22. Longitudinal intra-BBB IgG synthesis lasting up to eighteen years in patients with multiple sclerosis
23. Biochemical findings in multiple sclerosis. IV: Isoelectric focusing of the CSF gammaglobulin in multiple sclerosis (262 cases) and other neurological diseases (272 cases)
24. Probing for cerebrospinal fluid antibody specificities by a panel of random peptide libraries
25. Filter affinity transfer - A new technique for in situ identification of proteins in gels
26. Free kappa and lambda light chain levels in the cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases
27. Oligoclonal bands in multiple sclerosis: Clinical-pathologic correlation
28. Differentiation of the humoral immune response in inflammatory diseases of the central nervous system
29. Cerebrospinal fluid virus antibodies. A diagnostic indicator for multiple sclerosis
30. The compartmental IgM and IgA response within the central nervous system
31. Sensitivities and predictive values of paraclinical tests for diagnosing multiple sclerosis
32. Cerebrospinal fluid myelin basic protein, IgG and IgM levels in 101 patients before and after treatment with high-dose intravenous methylprednisolone
33. Cerebrospinal fluid IgG profiles and multiple sclerosis in Japan
34. Serum and cerebrospinal fluid antibodies against myelin basic protein and their IgG subclass distribution in multiple sclerosis
35. Antibody facilitation of multiple sclerosis-like lesions in a non human primate
36. Identification of autoantibodies associated with myelin damage in multiple sclerosis
37. The involvement of specific anti-myelin basic protein antibody-forming cells in multiple sclerosis immunopathology
38. Molecular immunologic strategies to identify antigens and B cell responses unique to multiple sclerosis
39. Diagnostic value of brief microzone electrophoresis of concentrated and unconcentrated CSF
40. Rapid analysis of immunoglobulin isoelectric focusing patterns with cellulose nitrate sheets and immunoperoxidase staining
41. Absence of measles, mumps and rubella viral genomic sequences from multiple sclerosis brain tissue by polymerase chain reaction
42. Oligoclonal borrelia burgdorferi-specific IgG antibodies in cerebrospinal fluid in Lyme neuroborreliosis
43. IgG subclass switching is associated with the severity of experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein peptide in NOD mice
44. Micromethod for detection of oligoclonal IgG in unconcentrated CSF by polyacrylamide gel electrophoresis
45. Toward a network theory of the immune system
46. An electrophoretic study of the proteins components in CSF and their relationship to serum proteins
47. Affinity immunoblotting: Rapid and sensitive detection of oligoclonal IgG, IgA and IgM in unconcentrated CSF by agarose isoelectric focusing
48. Electrophorese de proteins du liquid cephalorachidien
49. Isoelectric focusing of cerebrospinal fluid immunoglobulin G: An annotated update
50. Effector pathways in immune mediated central nervous system demyelination
51. Agarose isoelectric focusing of unconcentrated CSF and radioimmunofixation for detection of oligoclonal bands in patients with multiple sclerosis and other neurological diseases
52. Oligoclonal IgG bands in cerebrospinal fluid
53. Oligoclonal IgG bands in cerebrospinal fluid. Principles for demonstration and interpretation based on findings in 1114 neurological patients
54. Intrathecal synthesis of free immunoglobulin light chains in multiple sclerosis
55. Cross-reactive idiotypy in cerebrospinal fluid immunoglobulins in multiple sclerosis
56. Pathology of multiple sclerosis
57. Electrophoretic morphology of gammaglobulins in cerebrospinal fluid in multiple sclerosis and other diseases of the nervous system
58. Composition and variation of the gel electrophoretic fractions of plasma, CSF, and urine
59. Comparison between agarose gel electrophoresis and isoelectric focusing of CSF for demonstration of oligoclonal immunoglobulin bands in neurological disorders
60. Characterization of the mobility on isoelectric focusing of individual proteins in CSF and serum by immunofixation
61. Oligoclonal IgG and free light chains in multiple sclerosis demonstrated by thin-layer polyacrylamide gel isoelectric focusing and immunofixation
62. Local synthesis of IgA in the cerebrospinal fluid of patients with neurological diseases
63. Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: A prospective 2-years follow up with comparison of clinical evaluation, evoked potentials, oligoclonal banding and CT
64. IgG production within the central nervous system: A critical review of proposed formulae
65. Early onset of somatic mutation in immunoglobulin VH genes during the primary immune response
66. Immunoglobulin G and low molecular weight proteins in human CSF. Chemical and immunological characterization with special reference to MS
67. Immunoglobulin and measles antibodies in SSPE. Demonstration of synthesis of oligoclonal IgG with measles antibody activity within the CNS
68. Viral antibodies in oligoclonal and polyclonal IgG synthesized within the central nervous system over the course of mumps meningitis
69. Utility of isoelectric focusing of cerebrospinal fluid and serum on agarose evaluated for neurological patients
70. Chronic progressive myelopathy associated with HTLV-I: Oligoclonal IgG and anti-HTLV-I IgG antibodies in cerebrospinal fluid and serum
71. The cerebrospinal fluid in multiple sclerosis
72. B cells and autoimmunity
73. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein
74. Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody
75. Measurement of free kappa immunoglobulin light chains in the cerebrospinal fluid by a competitive avidin-biotin ELISA
76. Intrathecal synthesis of IgG, IgA, IgM and IgD in untreated multiple sclerosis and controls
77. Intrathecal synthesis of free immunoglobulin light chains and IgM in initial multiple sclerosis
78. Antibodies specific for the lipid-bound form of myelin basic protein during experimental autoimmune encephalomyelitis
79. Identification of IgG subclasses' oligoclonal bands in multiple sclerosis CSF
80. The differential diagnosis of neurological diseases by fractionating electrophoretically the CSF immunoglobulins
81. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
82. Isoelectric focusing versus quantitative measurement in the detection of intrathecal local synthesis of IgG
83. B-cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide
84. Alu sequences in the coding regions of mRNA: A source of protein variability
85. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis
86. Cells producing antibodies specific for myelin basic protein region 70-89 are predominant in cerebrospinal fluid from patients with multiple sclerosis
87. Induction of experimental autoimmune encephalomyelitis in rats and immune response to myelin basic protein in lipid-bound form
88. Multiple sclerosis is associated with enhanced B cell responses to the ganglioside GD1a
89. Isoelectric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis
90. Comparison of agar gel electrophoresis and isoelectric focusing in multiple sclerosis and subacute sclerosing panencephalitis
91. Light chains composition of oligoclonal IgG bands in multiple sclerosis and subacute sclerosing panencephalitis
92. A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isoelectric focusing and the log IgG-index
93. Oligoclonal IgG bands in plaques from multiple sclerosis brains
94. Detection of oligoclonal bands in unconcentrated CSF: Isoelectric focusing and silver staining
95. Absence of oligoclonal IgA in CSF and serum of multiple sclerosis patients
96. Silver staining of unconcentrated CSF in agarose gel (Panagel) electrophoresis
97. Occurrence of oligoclonals bands in multiple sclerosis and other CNS diseases
98. Synergy between encephalitogenic T cells and myelin basic protein-specific antibodies in the induction of experimental autoimmune encepalomyelitis
99. PCR-mediated search for herpes simplex virus DNA in sections of brain from patients with multiple sclerosis and other neurological disorders
100. Prognosis of optic neuritis with special reference to cerebrospinal fluid immunoglobulins and measles virus antibodies
101. Relationship between measles virus-specific antibody activities and oligoclonal IgG in the CNS of patients with SSPE and MS
102. Immunoglobulin abnormalities in multiple sclerosis
103. Gammaglobulins of CSF and serum in MS: Isoelectric focusing in polyacrylamide gel and agar gel electrophoresis
104. Improved detection of oligoclonal IgG in cerebrospinal fluid by isoelectric focusing in agarose, double-antibody peroxidase labeling, and avidin-biotin amplification
105. Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis
106. The 5 years risk of MS after optic neuritis: Experience of the Optic Neuritis Treatment Trial
107. H 4 germline segments in an acute multiple sclerosis brain
108. Cloning the antibody response in human with chronic inflammatory disease: Immunopanning of subacute sclerosing panencephalitis (SSPE) brain sections with antibody phage libraries prepared from SSPE brain enriches for antibody recognizing measles virus antigens in situ
109. The immunoglobulin G heavy chain repertoire in multiple sclerosis plaques is distinct from the heavy chain repertoire in peripheral blood lymphocytes
110. Activation of expression of multiple subfamilies of human Alu elements by adenovirus type 5 and herpes simplex virus type 1
111. A prospective study on the predictive value of CSF oligoclonal bands and MRI in acute isolated neurological syndromes for subsequent progression to multiple sclerosis
112. Specificity of immunoglobulins synthesized within the CNS in neurosyphilis
113. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: Requirement for Lyt 1+2-T lymphocytes
114. The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement
115. Cryptococcus neoformans-specific oligoclonal immunoglobulins in CSF in cryptococcal meningitis
116. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
117. The structure of chronically active multiple sclerosis plaques
118. Multiple sclerosis: Capping of surface immunoglobulin G on macrophages engaged in myelin breakdown
119. H genes of B cells from cerebrospinal fluid in multiple sclerosis
120. Agarose isoelectric focusing, antiserum immunofixation and silver staining for detection of oligoclonal bands in unconcentrated cerebrospinal fluid
121. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: A case for antigen-specific antibody mediation
122. Molecular approach to find target(s) for oligoclonal bands in multiple sclerosis
123. Improved methods for the application of random peptide phage libraries to the study of the oligoclonal bands in cerebrospinal fluid of patients with multiple sclerosis
124. Clonally related IgM rheumatoid factors undergo affinity maturation in the rheumatoid synovial tissue
125. Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system
126. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: Sensitive and specific detection of antibody synthesis in brain
127. Flow rate of cerebrospinal fluid (CSF) - A concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases
128. The hyperbolic function: A mathematical solution of the protein flux/CSF flow model for blood-CSF barrier function
129. Cerebrospinal fluid-physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases
130. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases
131. Immunoglobulins promote remyelination in the CNS
132. Cerebrospinal fluid in acute optic neuritis: Experience of the optic neuritis treatment trial
133. Specificity of antibodies in oligoclonal bands in patients with multiple sclerosis and cerebrovascular diseases
134. Isolated idiopathic optic neuritis. Analysis of free κ-light chains in cerebrospinal fluid and correlation with nuclear magnetic resonance findings
135. Multiple Sclerosis: The problem of misdiagnosis
136. Relative diagnostic value of cerebrospinal fluid kappa chains in MS: Comparison with other immunoglobulin tests
137. Free kappa light chains in multiple sclerosis spinal fluid
138. B-Cell development and maturation
139. A long-term prospective study of optic neuritis: Evaluation of risk factors
140. Isoelectric focusing in agarose
141. Central nervous system IgG synthesis in multiple sclerosis: Application of a new formula
142. A new strategy for the study of intrathecal immunity
143. Multiple sclerosis and intrathecal IgA synthesis
144. Immunoglobulin M in cerebrospinal fluid: An indicator of recent immunological stimulation
145. Intrathecal synthesis of IgM in neurological diseases: A comparison between detection of oligoclonal bands and quantitative estimation
146. Intrathecal immunoglobulin M synthesis in multiple sclerosis. Relationship with clinical and cerebrospinal fluid parameters
147. The predictive value of intrathecal immunoglobulin synthesis and magnetic resonance imaging in acute isolated syndromes for subsequent development of multiple sclerosis
148. The role of clonal selection and somatic mutation in autoimmunity
149. Induction of autoimmunity: A role for the idiotypic network
150. Antibodies to viral and non-viral antigens in SSPE and MS demonstrated by thin-layer polyacrylamide gel isoelectric focusing, antigen immunofixation and autoradiography
151. The concentration of IgM in the cerebrospinal fluid of neurological patients
152. Intrathecal synthesis of anti-mycobacterial antibodies in patients with tuberculous meningitis. An immunoblotting study
153. Oligoclonal free kappa and lambda bands in the cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. An immunoaffinity-mediated capillary blot study
154. Occurrence of oligoclonal IgM bands in the cerebrospinal fluid of neurological patients: An immunoaffinity-mediated capillary blot study
155. Polyclonal and oligoclonal IgA synthesis in the cerebrospinal fluid of neurological patients: An immunoaffinity-mediated capillary blot study
156. Comparison of immunoglobulin G heavy-chain sequences in MS and SSPE brains reveals an antigen-driven response
157. Viral damage and the breakdown of self-tolerance
158. Relation between benign course of multiple sclerosis and low grade humoral immune response in cerebrospinal fluid
159. Multiple sclerosis: In situ evidence for antibody- and complement-mediated demyelination
160. Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease: The salivary glands of patients with Sjögren's syndrome
161. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls
162. T and B cell responses to myelin oligodendrocyte glycoprotein in multiple sclerosis
163. Optic neuritis. Prognosis for multiple sclerosis from MRI, CSF, and HLA findings
164. Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values
165. On cerebrospinal fluid IgG quotients in multiple sclerosis and other diseases. A review and new formula to estimate the amount of IgG synthesized per day by the central nervous system
166. Schemes to eradicate the multiple sclerosis central nervous system immune reaction
167. Multiple sclerosis: The blood-brain-barrier and the measurement of the novo central nervous system IgG synthesis
168. Multiple sclerosis de novo CNS IgG synthesis: Effect of ACTH and corticosteroids
169. Multiple sclerosis: Measurement and validation of central nervous system IgG synthesis rate
170. The cerebrospinal fluid in multiple sclerosis
171. Multiple sclerosis cerebrospinal fluid
172. The role of anti-myelin (auto)-antibodies in the phagocytosis of myelin by macrophages
173. Oligoclonal IgG antibody response in the central nervous system to different measles virus antigens in subacute sclerosing panencephalitis
174. IgG1 subclass restriction of oligoclonal IgG from cerebrospinal fluids and brain extracts in patients with multiple sclerosis and subacute encephalitis
175. Oligoclonal measles virus specific IgG antibodies isolated from CSF, brain extracts and sera from patients with SSPE and MS
176. Progressive rubella virus panencephalitis: Synthesis of oligoclonal virus-specific IgG antibodies and homogeneous free light chains in the CNS
177. Multiple sclerosis: Subclasses of intrathecally synthesized IgG and measles and varicella zoster virus IgG antibodies
178. A rapid method for detecting oligoclonal IgG in unconcentrated CSF, by agarose isoelectric focusing, transfer to cellulose nitrate and immunoperoxidase staining
179. Central nervous system immunoglobulin synthesis in neurological diseases. Quantitation, specificity and regulation
180. Immunoglobulin G, A and M-clonal restriction in multiple sclerosis cerebrospinal fluid and serum-analysis by two dimensional electrophoresis
181. Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA and IgM in multiple sclerosis
182. Dual implication of 2′,3′-cyclic nucleotide 3 phosphodiesterase as major autoantigen and C3 complement-binding protein in the pathogenesis of multiple sclerosis
183. Enhancement of EAE and induction of autoantibodies to T-cell epitopes in mice infected with a recombinant vaccinia virus encoding myelin proteolipid protein
184. Increased synthetic peptide specificity of tissue-CSF bound anti-MBP in multiple sclerosis
185. Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis
186. Immunoglobulin-deficient rats fail to develop experimental allergic encephalomyelitis
187. Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2 restricted T cell clones from multiple sclerosis patients: Identity of key contact residues in the B-cell and T-cell epitopes
188. Idiotypic and antiidiotypic T and B lymphocytes in myasthenia gravis
189. The significance of serum oligoclonal bands in neurological diseases
190. A study of oligoclonal band negative multiple sclerosis
191. An idio-type shared by monoclonal antibodies to different peptides of human myelin basic protein
192. Specific modulation of T cells and murine experimental allergic encephalomyelitis by monoclonal anti-idiotypic antibodies
193. A cross-reactive anti-myelin basic protein idiotope in cerebrospinal fluid cells in multiple sclerosis
194. An improved formula for the judgement of intrathecally produced IgG in the presence of blood brain barrier damage
195. Comparison of seven formulae and isoelectrofocusing for determination of intrathecally produced IgG in neurological diseases